Former Argos Therapeutics CEO Jeff Abbey has found a new company to lead.
This week, Belgium-based Novadip Biosciences announced the appointment of Abbey as their CEO, replacing founding CEO Jean-Francois Pollet at the company near the start of the new year.
Novadip researches stem cell therapies. Its lead candidate is in phase 2 testing as a treatment for spinal fusion patients.
Abbey joins Novadip after leading Argos for more than 15 years. On November 30, the company announced his termination…
